Shanmuga Hospital

Shanmuga Hospital

42.65
-42.65
(-100.00%)
hide
Key Fundamentals
Add Ratio
Market Cap
56.10 Cr
EPS
4.03
PE Ratio
13.80
Dividend Yield
0.00 %
Industry
-
52 Week High
54.00
52 Week Low
31.00
PB Ratio
1.46
Debt to Equity
0.29
Sector
-
Forecast For
Actual

Company News

View All News
Caret
positive
Shanmuga Hospital Limited filed a statement confirming no deviations in the utilization of IPO proceeds during the half year ended September 30, 2025. The company raised Rs 2,061.72 lakhs through its IPO with allotment date of February 18, 2025. The opening unutilized IPO proceeds of Rs 1,115.50 lakhs as of March 31, 2025 were fully utilized during May 2025 for the purchase and installation of a robotic surgical machine under capital expenditure. The total IPO funds were allocated across capital expenditure (Rs 1,452.50 lakhs), issue expenses (Rs 225.94 lakhs), and general corporate purposes (Rs 383.28 lakhs). The statement was reviewed by the Audit Committee and approved by the Board on November 12, 2025. External auditors PPN and Company certified that there were no deviations in the use of public issue proceeds for the reporting period.
positive
Shanmuga Hospital Limited announced its unaudited financial results for the half-year ended September 30, 2025. The company reported a net profit of ₹201.13 lakhs compared to ₹181.38 lakhs in the previous period and ₹239.29 lakhs in the corresponding period last year. Revenue from operations stood at ₹2,462.07 lakhs. Total expenses were ₹2,201.68 lakhs, with cost of consumption being the largest component at ₹813.05 lakhs, followed by other expenses at ₹828.12 lakhs and employee benefits expense at ₹366.76 lakhs. The company's earnings per share was ₹1.48 for both basic and diluted calculations. The company completed full utilization of its IPO proceeds of ₹2,061.72 lakhs during the reporting period, with ₹1,452.50 lakhs allocated to capital expenditure and ₹383.28 lakhs for general corporate purposes. The Board of Directors approved these results at their meeting held on November 12, 2025.
neutral
Shanmuga Hospital Limited has issued a correction to their investor presentation, updating the number of inpatients and outpatients. The revised presentation has been made available on the company's website. The hospital, established in 1981 and based in Salem, Tamil Nadu, operates 140 beds out of 150+ bed capacity and recently listed on BSE SME in 2025. For FY2024-25, the company reported revenue of ₹4,785.33 lakhs with 11.2% growth, though EBITDA declined 2.8% to ₹817.09 lakhs and PAT fell 19.8% to ₹420.67 lakhs. The hospital handled 25,440 inpatients and 43,053 outpatients with an average occupancy rate of 49.78%. The company has strategic initiatives including launching a Nephro Care Center, adding 50 inpatient beds, and introducing renal transplant services.
View more
Growth Rate
Revenue Growth
10.83 %
Net Income Growth
-19.23 %
Cash Flow Change
-231.94 %
ROE
-65.39 %
ROCE
-60.25 %
EBITDA Margin (Avg.)
-14.55 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
42
40
43
48
0
Expenses
32
32
34
40
0
EBITDA
9
7
9
9
0
Operating Profit %
22 %
19 %
20 %
17 %
0 %
Depreciation
0
1
1
2
0
Interest
0
0
1
1
0
Profit Before Tax
9
7
7
6
0
Tax
2
2
2
2
0
Net Profit
7
5
5
4
0
EPS in ₹
6.91
4.90
5.36
4.03
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
11
23
34
53
Fixed Assets
2
10
16
22
Current Assets
8
13
14
30
Capital Work in Progress
0
0
4
0
Investments
0
0
0
0
Other Assets
8
13
14
30
Total Liabilities
11
23
34
53
Current Liabilities
4
7
13
9
Non Current Liabilities
0
4
4
4
Total Equity
7
12
17
40
Reserve & Surplus
7
12
7
26
Share Capital
0
0
10
14

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
2
-1
-1
Investing Activities
-2
-8
-12
-5
Operating Activities
2
3
10
-13
Financing Activities
0
7
1
16

Share Holding

% Holding
Dec 2024
Feb 2025
Mar 2025
Sept 2025
Promoter
71.95 %
71.95 %
72.11 %
72.06 %
FIIs
0.00 %
0.00 %
0.19 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.92 %
25.92 %
24.48 %
24.76 %
Others
2.13 %
2.13 %
3.22 %
3.19 %
No of Share Holders
1,772
9
1,449
1,156

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 42.50 42.65
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 38.10 38.50
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 45.65 48.00

Announcements

Statement On Deviation Or Variation12 hours ago
Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.12 hours ago
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.12 hours ago
Board Meeting Intimation for To Approve The Unaudited Financial Results For The Half Year Ended On 30Th September 20258 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 08, 2025
Shanmuga Hospital Limited Honoured At Times Healthcare Achievers - Tamil Nadu 2025 For Contribution To HealthcareSep 30, 2025
Closure Of Shanmuga ClinicsSep 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 25, 2025
Closure of Trading WindowSep 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 22, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Intimation Of Book Closure For The Purpose Of 05Th Annual General Meeting Of The Company.Sep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Reg. 34 (1) Annual Report.Aug 25, 2025
Notice Of The 05Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 19Th September 2025 At 03.00 P.M. Through Video Conference Or Other Audio Visual Means.Aug 25, 2025
Intimation Regarding Commissioning And Operationalization Of PH Impedance & Manometry SystemAug 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Intimation Regarding Operationalization Of CT ScannerAug 06, 2025
Board Meeting Intimation for To Fix The Date Of AGMAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
CLOSURE OF PHARMACY UNITJun 03, 2025
Statement On Deviation Or VariationMay 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2025
Audited Financial Results For The Financial Year Ended 31St March 2025.May 28, 2025
Board Meeting Outcome for Approval Of Audited Financial Statements For The Financial Year 2024-25May 28, 2025
Board Meeting Intimation for Approving The Audited Financial Results For The Half Year / Year Ended 31St March 2025.May 21, 2025
Intimation Regarding Operationalization Of Robotic Surgical EquipmentMay 11, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Intimation About Change In CIN Of The CompanyApr 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements Regulations) 2015Mar 31, 2025
Intimation Under Regulation 8(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations) For Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Appointment of Company Secretary and Compliance OfficerMar 31, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Mar 07, 2025
Announcement under Regulation 30 (LODR)-Change in RTAFeb 21, 2025
Appointment of Company Secretary and Compliance OfficerFeb 21, 2025
Intimation Under Regulation 8(2) Of The Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Feb 21, 2025

Technical Indicators

RSI(14)
Neutral
43.60
ATR(14)
Less Volatile
2.18
STOCH(9,6)
Neutral
50.96
STOCH RSI(14)
Neutral
38.88
MACD(12,26)
Bearish
-0.24
ADX(14)
Weak Trend
15.51
UO(9)
Bearish
51.83
ROC(12)
Downtrend And Accelerating
-6.16
WillR(14)
Neutral
-47.44